drugset
drugset / Trial / NCT00964457

Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

NCT00964457 ↗

Phase 2 Unknown 60 enrolled Copenhagen University Hospital at Herlev
Non-randomizedParallel-groupOpen-labelTreatment

Summary

response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer

Timeline

Start
2009-08
Primary completion
2012-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetuximab Monoclonal antibody 500 mg/m2 —

Indications

rectal cancer